Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort added to Atrovent and Theophylline in severe COPD
NCT01415518Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Sep 2011; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01415518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415518.